Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Subscribe and saveSummer Special! Upgrade here at £2.99/m (25% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Celltrion
Biotech
Topics

Advertisement

Celltrion

Share

Top Latest Popular

🌡️ HOT OFF THE PRESS! £2.99 a month for NewsNow Essentials. Upgrade here

🌡️ HOT OFF THE PRESS: NewsNow Essentials at just £2.99 a month. Faster, slicker, customisable & ad free. Upgrade here

Celltrion widens Omlyclo contracts in Italy as new biosimilars gain traction Korea Biomedical Review 07:31 Fri, 31 Jul

Korea Biomedical Review 07:31 Fri, 31 Jul

Italy Italian Politics

Southern Europe

Celltrion targets European secukinumab market with EMA filing for CT-P55 JD Supra 6d

JD Supra 6d

European Medicines Agency Arthritis

Celltrion wins new biosimilar contracts, expands supply in Italy Asia Today 02:31 Fri, 31 Jul

Asia Today 02:31 Fri, 31 Jul

Italy Italian Politics

Southern Europe

Advertisement

Advertisement

Celltrion expands US Pbm coverage for follow-on biosimilars Korea Biomedical Review 7d

Korea Biomedical Review 7d

Celltrion Q2 net profit jumps nearly sixfold on strong biosimilar sales Yonhap News Agency 01:50 Mon, 27 Jul

Yonhap News Agency 01:50 Mon, 27 Jul

Celltrion chief embarks on global tour to accelerate overseas sales The Korea Times 5d

The Korea Times 5d

Advertisement

Advertisement

Latest

Thursday

Celltrion’s record quarter sparks target-price upgrades The Korea Herald 06:35 Thu, 06 Aug

Wednesday

Celltrion chief embarks on global tour to accelerate overseas sales The Korea Times 05:09 Wed, 05 Aug

In the last month

Celltrion Targets European Secukinumab Market with EMA Filing for CT-P55 JD Supra 19:38 Mon, 03 Aug

Celltrion expands US PBM coverage for follow-on biosimilars Korea Biomedical Review 07:19 Mon, 03 Aug

Celltrion widens Omlyclo contracts in Italy as new biosimilars gain traction Korea Biomedical Review 07:31 Fri, 31 Jul

Celltrion wins new biosimilar contracts, expands supply in Italy Asia Today 02:31 Fri, 31 Jul

Kaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japan PR Newswire (Press Release) 02:02 Fri, 31 Jul

Celltrion to unveil obesity drug milestone before year-end The Korea Herald 06:45 Wed, 29 Jul

Celltrion to unveil obesity drug data this year, first ADC clinical readouts in 2027 Korea Biomedical Review 02:33 Wed, 29 Jul

Celltrion sets fresh earnings record on newer biosimilars The Korea Herald 06:47 Mon, 27 Jul

Advertisement

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna